See inside every stock. Pro
S&P 5007,723▲ 0.60%Nasdaq26,478▲ 1.18%Dow Jones52,378▲ 0.03%Nasdaq 10029,651▲ 1.29%VIX17.52▼ 4.73%US Dollar102.35▲ 0.39%Gold spot4,006▲ 0.30%WTI101.93▲ 2.03%
← SRV1V page
XStocksXray
Market X-Ray report · 27 October 2026

SRV Group plc (SRV1V)

Nasdaq Helsinki · Finland · prices in EUR · close of 27 Oct 2026

Key indicators

Last closeEUR 7.800
52-week range4.120 – 10.300
Return, 1 month / 3 months−18.8% / +45.5%
Return, 1 year / 3 years+47.7% / +129.4%
TrendAbove 200-day, below 50-day
RSI (14)40
Volatility (1 year)47.5%
Worst drawdown (1 year)-22.0%
Average daily value traded0.24M EUR
Dividend yield–

Market X-Ray price-based

72/ 100 · High confidence · ahead of 83% of stocks on this exchange
Trend81
Momentum95
Stability (higher is calmer)43
Liquidity65
Income–

Five-year price chart navy: price · brown: 200-day average

2.515.718.9112.1115.302021-102023-012024-042025-072026-10

About the company

SRV Group plc is a Finnish construction and project development company based in Espoo. It builds and develops residential housing, commercial and office premises, and infrastructure and renovation projects, working with private customers, businesses and public-sector clients. The company carries out construction contracting and acts as a developer on its own projects, and it operates mainly in Finland, with some activity in neighbouring markets.

On this site SRV Group plc appears as a stock on the Nasdaq Helsinki (Finland), code SRV1V, with prices in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

SRV Group plc (SRV1V) trades on the Nasdaq Helsinki in Finland. It last closed at EUR 7.800 on 27 October 2026.

Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 33 of 190 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 47.7% and over the last three months it rose 45.5%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
SRV Group plc (SRV1V)

The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Helsinki

Lens and metricValueScoreReading
Trend81 · StrongTrading above its long-term averages and near its highs.
Above 200-day average26.4%
From 52-week high-22.0%
Momentum95 · StrongRising faster than most stocks on this exchange.
3-month return45.5%
6-month return49.4%
12-month return, skipping the last month81.8%
Stability (higher is calmer)43 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)47.5%
Worst drawdown, 1 year (smaller is calmer)-22.0%
Liquidity65 · FairModerate trading activity.
Average daily value traded0.24M EUR
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−7.1%
1 month−18.8%
3 months+45.5%
6 months+49.4%
1 year+47.7%
3 years+129.4%
5 years−46.6%

Signals

50-day / 200-day average8.741 / 6.173
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.592

Technical summary

DailyNeutral7 bullish · 1 neutral · 8 bearish
WeeklyStrongly bullish9 bullish · 1 neutral · 2 bearish
MonthlyStrongly bullish7 bullish · 1 neutral · 0 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Helsinki; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 28 Oct 2026